Pfizer will ship certain sterile injectable products directly to customers under an emergency ordering process implemented yesterday due to high demand for the products after a tornado struck the North Carolina plant that makes them, the company announced yesterday. Until further notice, customers should place orders for these products through their Pfizer Hospital representative or by calling the Pfizer Hospital Supply Continuity Team. Products that were in limited supply prior to the tornado also may still have allocations in place, the company said. While Pfizer continues to post the status report for all its injectable products, the next delivery and estimated recovery dates for products made at the plant will not be accurate until further notice, the company said.

Related News Articles

Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…